High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam
To curb HIV infection rate in Tanzania, antiretroviral therapy (ART) has been scaled up since
2006, and in 2019, the country shifted to regimen including dolutegravir as a default first line …
2006, and in 2019, the country shifted to regimen including dolutegravir as a default first line …
Factors associated with viral suppression and drug resistance in children and adolescents living with HIV in care and treatment programs in southern Tanzania
SA Khamadi, E Bahemana, N Dear… - Journal of the …, 2023 - academic.oup.com
Background Achieving viral suppression (VS) for persons living with HIV is key to reaching
epidemic control. We assessed the prevalence of VS and the frequency of HIV drug …
epidemic control. We assessed the prevalence of VS and the frequency of HIV drug …
Viral suppression and adherence in adolescents living with HIV in rural Tanzania
E Luoga, J Okuma, L Moshi, G Sigalla, D Mnzava… - PloS one, 2024 - journals.plos.org
Background Adolescents living with HIV (ALHIV) in sub-Saharan Africa are affected by poor
treatment outcomes, likely a consequence of poor adherence. Objectives To assess viral …
treatment outcomes, likely a consequence of poor adherence. Objectives To assess viral …
Pretreatment and acquired HIV drug resistance in Belize—results of nationally representative surveys, 2021–22
F Morey, A Girón-Callejas, R Manzanero… - Journal of …, 2025 - academic.oup.com
Background The rising prevalence of pretreatment drug resistance (PDR) to non-nucleoside
reverse-transcriptase inhibitors threatens the effectiveness of ART. In response, the WHO …
reverse-transcriptase inhibitors threatens the effectiveness of ART. In response, the WHO …
Prevalence and predictors of persistent low-level HIV viraemia: a retrospective cohort study among people receiving dolutegravir-based antiretroviral therapy in …
Background: Persistent low-level viraemia (PLLV) is a risk factor for virologic failure among
people receiving antiretroviral therapy (ART). Objectives: We assessed the prevalence and …
people receiving antiretroviral therapy (ART). Objectives: We assessed the prevalence and …
VIRAL LOAD SUPPRESSION AND ASSOCIATED FACTORS AMONG HIV-INFECTED PATIENTS ON SECOND-LINE ANTIRETROVIRAL THERAPY AT PUBLIC …
D Hailu, D Jara, A Edin, A Awol, A Ayele, Y Fekadu… - medRxiv, 2024 - medrxiv.org
Background Ethiopia is one of the nation's most severely impacted by HIV, with an estimated
700,000 people living with HIV/AIDS. Hence, many health facilities were providing second …
700,000 people living with HIV/AIDS. Hence, many health facilities were providing second …
[PDF][PDF] George M. Bwire, Beatrice Godwin Aiko 3, 4, Idda H. Mosha 5, Mary S. Kilapilo 2, Alli Mangara 6, Patrick Kazonda 6, Janeth P. Swai 7, Omary Swalehe 7 …
AM Vandamme - Scientific Reports, 2023 - run.unl.pt
To curb HIV infection rate in Tanzania, antiretroviral therapy (ART) has been scaled up since
2006, and in 2019, the country shifted to regimen including dolutegravir as a default first line …
2006, and in 2019, the country shifted to regimen including dolutegravir as a default first line …
Evaluating Second-line ART Efficacy in Pediatric HIV1 Infections: A Study at Albert Royer Children's Hospital
D Baïdy, D Amadou, NA Ahmet… - … of Advances in …, 2023 - science.sdpublishers.org
Introduction: In developing countries, around 15% of children infected with the Human
Immunodeficiency Virus (HIV) have access to early diagnosis, and 28% are eligible for …
Immunodeficiency Virus (HIV) have access to early diagnosis, and 28% are eligible for …
[PDF][PDF] Dolutegravir resistance in three pregnant and breastfeeding women in South Africa
Dolutegravir (DTG) has superior efficacy, safety, tolerability, and a better resistance profile
compared with non-nucleoside reverse transcriptase inhibitors (NNRTI), making it the …
compared with non-nucleoside reverse transcriptase inhibitors (NNRTI), making it the …